Liaoning Boao Bio-pharmaceutical Co., Ltd. is a modern biopharmaceutical enterprise integrating R&D and production of insulin series products. It covers an area of 35,000 square meters and a building area of 20,000 square meters. The existing fixed assets are nearly 200 million RMB. The company's products are mainly the world's leading genetic recombinant protein drug recombinant human insulin, and its long-acting analogs insulin glargine, and fast-acting analogs insulin aspart. This project was built in 2020, the designed purification level is ABC, and the main production equipments all imported from Germany. The purification area is 6,300 square meters. The project uses domestic first-class building materials and construction technology, the whole workshop uses modern BIM to model and guide the construction, a high degree of automatic control and intelligent design of the whole workshop.